Showing results (241-250 of 269) with videos related to
Sort By:
Pageof 27
Cell Reports. Medicine|September 27, 2024
A candidate loss-of-function variant in SGIP1 causes synaptic dysfunction and recessive parkinsonismMarianna Decet, Patrick Scott, Sabine Kuenen, et al.Scientific Reports|March 7, 2025
Clinical and brain functional correlates of instrumental rigidity measurement in Parkinson's diseaseYoshikazu Nakano, Shigeki Hirano, Mitsuyoshi Tamura, et al.Dystonia (Lausanne, Switzerland)|July 10, 2026
Brain network pathophysiology in dystoniaDavid A Peterson, Myungjoo Kim, Robert Chen, et al.The Lancet. Neurology|January 27, 2024
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 studyRalf Reilmann, Karen E Anderson, Andrew Feigin, et al.Archives of Neurology|February 10, 2010
A randomized, placebo-controlled trial of latrepirdine in Huntington diseaseKarl Kieburtz, Michael P McDermott, Tiffini S Voss, et al.Journal of Huntington'S Disease|May 3, 2024
What Huntington's Disease Patients Say About Their Illness: An Online Direct-to-Participant Pilot StudyKaren E Anderson, Lakshmi Arbatti, Abhishek Hosamath, et al.Biorxiv : the Preprint Server for Biology|September 16, 2024
Early brain neuroinflammatory and metabolic changes identified by dual tracer microPET imaging in mice with acute liver injurySanthoshi P Palandira, Aidan Falvey, Joseph Carrion, et al.Parkinsonism & Related Disorders|February 2, 2021
Art therapy for Parkinson's diseaseAlberto Cucca, Alessandro Di Rocco, Ikuko Acosta, et al.Cell Metabolism|March 2, 2022
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's diseaseBrage Brakedal, Christian Dölle, Frank Riemer, et al.Theranostics|February 16, 2026
Non-invasive identification of brain signatures of acute liver injurySanthoshi P Palandira, Aidan Falvey, Joseph Carrion, et al.Pageof 27